Results 321 to 330 of about 95,583 (387)
Have Your Sodium-Glucose Cotransporter 2 Inhibitor-Derived Ketones and Eat Them Too. [PDF]
Hahn VS, Koleini N.
europepmc +1 more source
Mode of death stratified by implantable cardioverter‐defibrillator (ICD) status. CI, confidence interval; CV, cardiovascular; HF, heart failure; HFrEF, heart failure with reduced ejection fraction; HR, hazard ratio; SCD, sudden cardiac death. Abstract Aims Guidelines recommend the use of implantable cardioverter‐defibrillators (ICDs) to reduce the risk
Pishoy Gouda+11 more
wiley +1 more source
Increasing Prescription of SGLT2 Inhibitors with Expanded Indications to the Elderly Population in Japan. [PDF]
Oda Y+4 more
europepmc +1 more source
Sex differences in heart failure (HF) management and outcomes in the French‐DataHF cohort. CI, confidence interval; HFH, heart failure hospitalization; HR, hazard ratio; IPW, inverse probability weighting; KM, Kaplan–Meier; LD, loop diuretic; RAS, renin–angiotensin system; RASi, renin–angiotensin system inhibitor.
Guillaume Baudry+7 more
wiley +1 more source
Early Initiation of Sodium-Glucose Cotransporter 2 Inhibitors in Acute Heart Failure: A Systematic Review and Meta-Analysis. [PDF]
Cherbi M+5 more
europepmc +1 more source
Hypoxia and acidic microenvironments are characteristic features of solid tumors, driving tumor growth, drug resistance, and metastasis. To address these issues, we combined hyperbaric oxygen therapy with rational designed hydroxyethyl starch‐doxorubicin‐copper nanoparticles to modulate the acidic microenvironment of tumors while enhancing the efficacy
Qingyuan Deng+9 more
wiley +1 more source
Real-world effectiveness of adding newer generation GLP-1RA to SGLT2i in type 2 diabetes. [PDF]
Chaiyakunapruk N+5 more
europepmc +1 more source
GABAergic mechanisms of excitation and hypersynchrony in adult rat hippocampus [PDF]
Uusisaari, Marylka
core
Evaluating Guideline Alignment by Analyzing Patient Profiles of Elderly People with Type 2 Diabetes and Chronic Kidney Disease Treated or Not with SGLT2 Inhibitors. [PDF]
Vafeidou K+9 more
europepmc +1 more source